JP2016086711A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016086711A5 JP2016086711A5 JP2014223742A JP2014223742A JP2016086711A5 JP 2016086711 A5 JP2016086711 A5 JP 2016086711A5 JP 2014223742 A JP2014223742 A JP 2014223742A JP 2014223742 A JP2014223742 A JP 2014223742A JP 2016086711 A5 JP2016086711 A5 JP 2016086711A5
- Authority
- JP
- Japan
- Prior art keywords
- ifn
- lactic acid
- acid bacteria
- inducing activity
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 16
- 241000894006 Bacteria Species 0.000 claims 8
- 235000014655 lactic acid Nutrition 0.000 claims 8
- 239000004310 lactic acid Substances 0.000 claims 8
- 230000001939 inductive effect Effects 0.000 claims 6
- 230000011488 interferon-alpha production Effects 0.000 claims 6
- 230000003308 immunostimulating effect Effects 0.000 claims 5
- 210000001185 bone marrow Anatomy 0.000 claims 4
- 210000004443 dendritic cell Anatomy 0.000 claims 4
- 239000001963 growth medium Substances 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 102000006992 Interferon-alpha Human genes 0.000 claims 2
- 108010047761 Interferon-alpha Proteins 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 229960001438 immunostimulant agent Drugs 0.000 claims 2
- 239000003022 immunostimulating agent Substances 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 239000006228 supernatant Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014223742A JP6455920B2 (ja) | 2014-10-31 | 2014-10-31 | 微生物又はｄｎａの免疫賦活活性を予測する方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014223742A JP6455920B2 (ja) | 2014-10-31 | 2014-10-31 | 微生物又はｄｎａの免疫賦活活性を予測する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016086711A JP2016086711A (ja) | 2016-05-23 |
| JP2016086711A5 true JP2016086711A5 (enExample) | 2017-09-28 |
| JP6455920B2 JP6455920B2 (ja) | 2019-01-23 |
Family
ID=56015276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014223742A Active JP6455920B2 (ja) | 2014-10-31 | 2014-10-31 | 微生物又はｄｎａの免疫賦活活性を予測する方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6455920B2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7090288B2 (ja) * | 2016-08-16 | 2022-06-24 | 株式会社ゲノム創薬研究所 | 新規乳酸菌、新規乳酸菌を有効成分として含有する自然免疫活性化剤、及び新規乳酸菌を含有する飲食品 |
| JP6796299B2 (ja) * | 2018-05-23 | 2020-12-09 | キッコーマン株式会社 | 免疫賦活用組成物及びサイトカイン産生促進用組成物 |
| JP6691275B1 (ja) * | 2018-08-09 | 2020-04-28 | キッコーマン株式会社 | ＦｃεＲＩの発現抑制用組成物及びＦｃεＲＩの発現抑制方法 |
| JPWO2024090413A1 (enExample) * | 2022-10-25 | 2024-05-02 | ||
| JP7854119B1 (ja) * | 2024-12-25 | 2026-04-30 | キリンホールディングス株式会社 | 免疫活性を判定する方法、及び免疫活性を判定するための装置 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2659898B1 (en) * | 2010-12-28 | 2018-03-07 | Kirin Holdings Kabushiki Kaisha | Use of lactococcus bacteria in the treatment or prevention of viral infections |
-
2014
- 2014-10-31 JP JP2014223742A patent/JP6455920B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
| EP4249036A3 (en) | Methods and products for nucleic acid production and delivery | |
| MX2021000211A (es) | Metodos y productos para transfeccion de celulas. | |
| FI3604532T3 (fi) | Uusia crispr-entsyymejä ja järjestelmiä | |
| JP2017529849A5 (enExample) | ||
| JP2014158488A5 (enExample) | ||
| WO2016205410A3 (en) | Defined multi-conjugate oligonucleotides | |
| PH12014500348A1 (en) | Genes and proteins for alkanoyl-coa synthesis | |
| MX2016008776A (es) | Proteína de fusión de inhibe angiogénesis o crecimiento y uso de la misma. | |
| WO2016210373A3 (en) | Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof | |
| EP4086347A3 (en) | Selective antisense compounds and uses thereof | |
| NZ700902A (en) | Lowering saturated fatty acid content of plant seeds | |
| NZ613335A (en) | Agent for inducing interferon production containing lactic acid bacteria | |
| WO2011091350A3 (en) | Methods & compositions for improving protein production | |
| WO2011075686A3 (en) | Methods & compositions comprising heat shock proteins | |
| IL269187B1 (en) | Dominant active yap, a hippo effector, induces chromatin accessiblity and cardiomyocyte renewal | |
| JP2016501515A5 (enExample) | ||
| HRP20201021T1 (hr) | Modificirane stanice domaćini i njihova upotreba | |
| EP2574170A4 (en) | IMMUNOSTIMULATORY AND VACCINE COMPOSITIONS | |
| WO2016081032A3 (en) | Mesenchymal stem cells derived from induced pluripotent stem cells | |
| MX352195B (es) | Genes que proporcionan resistencia al mildiú polvoroso en cucumis melo. | |
| EP4471130A3 (en) | New immunoregulatory cells and methods for their production | |
| MX2013005140A (es) | Medios de cultivo de celulas granulados en seco. | |
| UA115235C2 (uk) | Ген токсину axmi335 bacillus thuringiensis та спосіб його застосування | |
| MX2015015274A (es) | Ruta de ácido organico novedosa. |